Our findings correspond closely to previous researches on melanoma, esophageal, and triple-negative breast cancers, showing that high NM23-H1 expression correlated with favorable response to chemotherapy [9-11]. This evidence concerns the gene NME1 and triple-negative breast carcinoma.